Section Arrow
VERU.NASDAQ
- Veru
(Financial Status)
Quotes are at least 15-min delayed:2025/05/28 02:09 EDT
Last
 0.509
+0.0105 (+2.11%)
Day High 
0.5125 
Prev. Close
0.4985 
1-M High
0.56 
Volume 
1.52M 
Bid
0.5001
Ask
0.511
Day Low
0.4945 
Open
0.5 
1-M Low
0.48 
Market Cap 
73.07M 
Currency USD 
P/E -- 
%Yield 5.56 
10-SMA 0.51 
20-SMA 0.51 
50-SMA 0.53 
52-W High 1.42 
52-W Low 0.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.25/-0.26
Enterprise Value
84.84M
Balance Sheet
Book Value Per Share
0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
16.89M
Operating Revenue Per Share
0.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IMNNImunon2.27+1.11+95.69%-- 
RCKTRocket Pharmaceuticals2.33-3.94-62.84%-- 
NCNANuCana plc0.039+0.001+2.63%-- 
AEONAEON Biopharma0.607+0.073+13.67%0PE
SVRASavara1.94-0.9-31.69%-- 
Quotes are at least 15-min delayed:2025/05/28 02:09 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.